The International Consortium of Stem Cell Networks' (ICSCN) Workshop Towards Clinical Trials Using Stem Cells for Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND) was held in January 2011. Twenty scientific talks addressed aspects of cell derivation and characterization; preclinical research and phased clinical trials involving stem cells; latest developments in induced pluripotent (iPS) cell technology; and industry involvement and investment.
Three moderated panel discussions focused on unregulated ALS/MND treatments and the state of the art and barriers to future progress in using stem cells for ALS/MND. This review highlights the major insights that emanated from the workshop around the lessons learned and barriers to progress for using stem cells for understanding disease mechanism, drug discovery, and as therapy for ALS/MND.
The meeting was organized and sponsored by The ALS Association with funds provided by The Greater New York Chapter of The ALS Association; the MND Association, United Kingdom; The New York Stem Cell Foundation; the UK National Stem Cell Network; and the Stem Cell Network (Canada).
Click here to download a PDF of the full report.